socalTechnews
 
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Monday, March 24, 2008

    Trius Therapeutics Raises $30M
    San Diego-based Trius Therapeutics said today that it has raised $30M in a Series B funding round. The funding was led by Kleiner, Perkins, Caulfied and Byers. FinTech Global Capital, a new investor in the firm, also participated, along with existing backers Sofinnova Ventures, Versant Ventures, Interwest Partners and Prism VentureWorks. Trius Therapeutics is developing antibacterial drugs.
    posted on Monday, March 24, 2008 (Link to more information)

    Related companies:
    Trius Therapeutics

    Related stories:
    > Trius Therapeutics Finds $20M
    > Tobira Therapeutics Raises $31M
    > MabVax Therapeutics Raises $8M For Cancer Treatment
    > Invitrogen Invests In Q Therapeutics
    > CoDa Therapeutics Raises $10M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Thursday, May 15, 2008
    Wednesday, May 14, 2008
    Tuesday, May 13, 2008
    Monday, May 12, 2008
    Friday, May 9, 2008